Anti-interleukin (IL)-5 as a steroid-sparing agent in chronic eosinophilic pneumonia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-interleukin (IL)-5 as a steroid-sparing agent in chronic eosinophilic pneumonia

Published:2018-11-16 Issue:1 Volume:57 Page:82-86
ISSN:0277-0903
Container-title:Journal of Asthma
language:en
Short-container-title:Journal of Asthma

Author:

Sarkis Edmond¹,Patel Sumit¹,Burns Kenneth¹,Batarseh Hanan²,Mador M. Jeffery³⁴^ORCID

Affiliation:

1. Pulmonary and Critical Care, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA;

2. Internal Medicine, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA;

3. Medicine, University at Buffalo, Buffalo, New York, USA;

4. Medicine, Buffalo VAMC, , Buffalo, New York, USA

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology, and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/02770903.2018.1543434

Reference21 articles.

1. Idiopathic Chronic Eosinophilic Pneumonia: A Clinical and Follow-Up Study of 62 Cases

2. Incidence and aetiology of eosinophilic pleural effusion

3. Eosinophilic Pneumonias

4. Reslizumab for Poorly Controlled, Eosinophilic Asthma

5. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful Treatment of Relapsing Chronic Eosinophilic Pneumonia With Mepolizumab: A Case Report;Cureus;2024-07-22

2. The long-term outcomes of mepolizumab treatment at 100 mg dose on idiopathic chronic eosinophilic pneumonia: A real-life experience;Allergy and Asthma Proceedings;2024-07-01

3. Monoclonal antibodies in idiopathic chronic eosinophilic pneumonia: a scoping review;BMC Pulmonary Medicine;2024-02-08

4. Research Progress of Eosinophils and Chronic Rhinosinusitis;Advances in Clinical Medicine;2024

5. Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia;F1000Research;2023-09-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3